CLINICAL TRIALS PROFILE FOR WARFARIN SODIUM

All Clinical Trials for warfarin sodium

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Canadian Institutes of Health Research (CIHR)	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	Dupont Applied Biosciences	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	LEO Pharma	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203580 ↗	Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)	Completed	University of Calgary	Phase 4	1994-12-01	The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.
NCT00203658 ↗	Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin	Completed	Canadian Institutes of Health Research (CIHR)	Phase 4	1997-04-01	The purpose of this study is to assess the long-term out-of-hospital treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus low-molecular-weight heparin followed by warfarin sodium.

Clinical Trial Conditions for warfarin sodium

Condition Name

Condition Name for warfarin sodium
Intervention	Trials
Thrombosis	6
Venous Thrombosis	5
Healthy	4
Cirrhosis	3

Condition MeSH

Condition MeSH for warfarin sodium
Intervention	Trials
Thrombosis	12
Venous Thrombosis	7
Thromboembolism	5
Fibrosis	5

Clinical Trial Locations for warfarin sodium

Trials by Country

Trials by Country for warfarin sodium
Location	Trials
United States	69
Japan	13
China	7
Canada	6
Brazil	4

Trials by US State

Trials by US State for warfarin sodium
Location	Trials
Texas	4
Ohio	4
Utah	3
California	3
Maryland	3

Clinical Trial Progress for warfarin sodium

Clinical Trial Phase

Clinical Trial Phase for warfarin sodium
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	8
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for warfarin sodium
Clinical Trial Phase	Trials
Completed	19
Terminated	6
Unknown status	4

Clinical Trial Sponsors for warfarin sodium

Sponsor Name

Sponsor Name for warfarin sodium
Sponsor	Trials
Boehringer Ingelheim	4
Yangzhou University	3
Sanofi	2

Sponsor Type

Sponsor Type for warfarin sodium
Sponsor	Trials
Other	45
Industry	21
NIH	1